Stocks TelegraphStocks Telegraph
Stock Ideas

CVAC Company Profile and Key Details

NASDAQ : CVAC

CureVac N.V.

$4.14
0.04+0.98%
At Close 4:00 PM
$4.15
0.01+0.24%
After-Market 05:41 PM
63.3
B+ESG ScoreESG Rating

CVAC Stock Price Chart

Stock Price Today

CureVac N.V. (CVAC) stock surged +0.98%, trading at $4.14 on NASDAQ, up from the previous close of $4.10. The stock opened at $4.13, fluctuating between $4.02 and $4.26 in the recent session.

Stock Snapshot

4.1
Prev. Close
4.13
Open
928.63M
Market Cap
224.31M
Number of Shares
4.02
Day Low
4.26
Day High
8.63
P/E Ratio
41.74%
Free Float in %
0.48
EPS (TTM)
2.69
Book Value
-1.5
Cash Flow per Share
823.44K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 21, 20254.134.274.024.14823.44K
Jan 17, 20254.194.304.064.10590.1K
Jan 16, 20254.124.324.084.18945.23K
Jan 15, 20253.994.203.994.07820K
Jan 14, 20253.974.203.923.94981.18K
Jan 13, 20254.154.153.893.94770.62K
Jan 10, 20254.084.524.074.211.81M
Jan 08, 20254.364.373.874.232.77M
Jan 07, 20254.925.004.464.684.38M
Jan 06, 20254.144.463.934.442.94M
Jan 03, 20253.503.733.403.621.12M
Jan 02, 20253.363.663.323.451.22M
Dec 31, 20243.093.443.093.41890.02K
Dec 30, 20243.153.233.043.12418.35K
Dec 27, 20243.083.213.033.17833.14K
Dec 26, 20242.973.072.933.05300.68K
Dec 24, 20242.983.022.932.99177.12K
Dec 23, 20242.862.982.832.96436.18K
Dec 20, 20242.863.022.832.87820.94K
Dec 19, 20242.793.062.682.991.13M

Contact Details

Tübingen, 72076

Germany

Website: https://www.curevac.comContact: 497 071 98830

About Company

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

Company Information

Employees999
Beta2.61
Sales or Revenue$52.66M
5Y Sales Change%2.333%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current CureVac N.V. (CVAC) stock price?

CureVac N.V. (NASDAQ: CVAC) stock price is $4.14 in the last trading session. During the trading session, CVAC stock reached the peak price of $4.26 while $4.02 was the lowest point it dropped to. The percentage change in CVAC stock occurred in the recent session was 0.98% while the dollar amount for the price change in CVAC stock was $0.04.

CVAC's industry and sector of operation?

The NASDAQ listed CVAC is part of Biotechnology industry that operates in the broader Healthcare sector. CureVac N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CVAC?

Mr. Alexander Zehnder
Chief Executive Officer
Mr. Marco Rau L.L.M., Ph.D.
Gen. Counsel
Mr. Thorsten Schuller
Head of Corporation Communications
Slavica Stevanovic-Heck
Head of HR
Dr. Igor Splawski M.Sc., Ph.D.
Chief Scientific Officer & Member of Management Board
Dr. Ulrike Gnad-Vogt M.D., Ph.D.
Senior Vice President & Area Head of Oncology
Dr. Alexander Zehnder M.B.A., M.D.
Chief Executive Officer, MD & Member of Management Board
Dr. Sarah Fakih
Vice President Corporation Communications & Investor Relations
Dr. Alexander Zehnder
Chief Executive Officer & MD
Dr. Myriam Mendila M.D.
Chief Devel. Officer & Member of the Management Board
Dr. Franz-Werner Haas L.L.M., LL.M., LLD, Ph.D.
Managing Director
Dr. Alexander Zehnder L.L.M., Ph.D.
Chief Executive Officer, MD & Member of Management Board
Mr. Pierre Kemula B.Sc.
MD, Chief Financial Officer & Member of Management Board
Dr. Antony Blanc Ph.D.
MD, Chief Bus. Officer, Chief Commercial Officer & Member of Management Board
Mr. Malte Greune Ph.D.
Chief Operating Officer, Member of Management Board & MD

How CVAC did perform over past 52-week?

CVAC's closing price is 86.91% higher than its 52-week low of $2.22 where as its distance from 52-week high of $5.28 is -21.59%.

How many employees does CVAC have?

Number of CVAC employees currently stands at 999.

Link for CVAC official website?

Official Website of CVAC is: https://www.curevac.com

How do I contact CVAC?

CVAC could be contacted at phone 497 071 98830 and can also be accessed through its website. CVAC operates from Friedrich-Miescher-Strasse 15, Tübingen, 72076, Germany.

How many shares of CVAC are traded daily?

CVAC stock volume for the day was 823.44K shares. The average number of CVAC shares traded daily for last 3 months was 766.63K.

What is the market cap of CVAC currently?

The market value of CVAC currently stands at $928.63M with its latest stock price at $4.14 and 224.31M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph